Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials
Introduction Engaging people with cystic fibrosis (CF) in clinical trials is critical to improving outcomes for this fatal disease. Following extensive exploration of engagement in CF trials we believe six key concepts require a quantitative understanding of their influence in the current CF trials...
Main Authors: | Rebecca Anne Dobra, Marco Boeri, Stuart Elborn, Susan Madge |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/3/e045803.full |
Similar Items
-
Personalised medicine for cystic fibrosis: treating the basic defect
by: J. Stuart Elborn
Published: (2013-03-01) -
Modulator treatment for people with cystic fibrosis: moving in the right direction
by: J. Stuart Elborn
Published: (2020-03-01) -
A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF
by: Stephanie Thee, et al.
Published: (2021-04-01) -
Understanding the link between transglutaminase and the induction of fibrosis in cystic fibrosis (CF)
by: Nyabam, Samuel
Published: (2015) -
Early detection of <it>Pseudomonas aeruginosa </it>– comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
by: Moore John E, et al.
Published: (2004-10-01)